Injunction blocks first US biosimilar
Thursday, May 14, 2015 - 09:40
in Health & Medicine
Despite regulatory approval, Amgen is delaying sales of Sandoz’s version of filgrastim
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via